Spyre Therapeutics
SYRE
#4826
Rank
$1.50 B
Marketcap
$29.20
Share price
-6.62%
Change (1 day)
170.12%
Change (1 year)

Spyre Therapeutics (SYRE) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : $61.68 Million USD

According to Spyre Therapeutics's latest financial reports the company's total liabilities are $61.68 Million USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Spyre Therapeutics - Total liabilities on balance sheet (from 2014 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31$0.15 B657.44%
2022-12-31$20.83 M-19.8%
2021-12-31$25.98 M19.27%
2020-12-31$21.78 M-5.7%
2019-12-31$23.1 M124.05%
2018-12-31$10.31 M79.63%
2017-12-31$5.74 M40.1%
2016-12-31$4.09 M60.67%
2015-12-31$2.55 M141.02%
2014-12-31$1.05 M-25.07%
2013-12-31$1.41 M